GLP-1 Agonists, Including Semaglutide, May Reduce Addiction and Overdose Risks, Study Finds

Oct 17, 2024, 05:32 AM

A new study suggests that GLP-1 agonist medications, such as Ozempic, Wegovy, Mounjaro, Trulicity, and semaglutide, which are commonly used for diabetes management and weight loss, may also help reduce addictive behaviors and prevent opioid overdose. The study, which analyzed 1.3 million health records, found that among people with alcoholism, rates of alcohol intoxication were 50% lower, and among those with opioid addiction, overdose rates were 40% lower. Additionally, these medications were associated with 40% lower rates of hospitalizations for heroin overdose.